Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters

Database
Language
Publication year range
1.
J Cell Physiol ; 234(12): 23082-23096, 2019 12.
Article in English | MEDLINE | ID: mdl-31131449

ABSTRACT

In continuation of the investigation of osteogenic potential of solvent fractions of ethanolic extract of Cissus quadrangularis (CQ), an ancient medicinal plant, most notably known for its bone-healing properties, to isolate and identify antiosteoporotic compounds. In the current study, we report the effect of hexane fraction (CQ-H) and dichloromethane fraction (CQ-D) of CQ on the differentiation and mineralization of mouse preosteoblast cell line MC3T3-E1 (subclone 4). Growth, viability, and proliferation assays revealed that low concentrations (0.1, 1, and 100 ng/ml) of both solvent fractions were nontoxic, whereas higher concentrations were toxic to the cells. Differentiation and mineralization of MC3T3-E1 with nontoxic concentrations of CQ-D and CQ-H revealed that CQ-D delayed the mineralization of MC3T3-E1 cells. However, early and enhanced mineralization was observed in cultures treated with nontoxic concentrations of CQ-H, as indicated by Von Kossa staining and expression profile of osteoblast marker genes such as osterix, Runx2, alkaline phosphatase (ALP), collagen (Col1a1), integrin-related bone sialoprotein (IBSP), osteopontin (OPN), and osteocalcin (OCN). These findings suggest CQ-H as the most efficacious solvent fraction for further investigation to isolate and identify the active compounds in CQ-H.


Subject(s)
Cissus/chemistry , Osteoblasts/drug effects , Osteogenesis/drug effects , Plant Extracts/pharmacology , 3T3 Cells , Alkaline Phosphatase/genetics , Animals , Calcification, Physiologic/drug effects , Cell Differentiation , Cell Proliferation/drug effects , Collagen Type I/genetics , Collagen Type I, alpha 1 Chain , Gene Expression Regulation, Developmental/drug effects , Hexanes/chemistry , Methylene Chloride/chemistry , Mice , Osteopontin/genetics , Plant Extracts/chemistry
2.
J Clin Pathol ; 71(9): 840-844, 2018 Sep.
Article in English | MEDLINE | ID: mdl-29764932

ABSTRACT

AIMS: To identify the presence and geographical distribution of mast cell (MC) subtypes: MCT (tryptase positive-chymase negative) and MCTC (tryptase positive-chymase positive) in bladder tissue. METHODS: Bladder tissue was obtained from patients with painful bladder syndrome/interstitial cystitis (n=14) and normal histology from University Hospital Southampton tissue bank. Sequential tissue slices were immunohistochemically stained for MC subtypes using anti-MC tryptase (for MCT and MCTC) and anti-MC chymase (for MCTC). Stained sections were photographed, and positively stained MCs were quantified using ImageJ. Data were analysed using descriptive statistics and individual paired t-tests. RESULTS: There was a significant difference in the density of MCs between each layer of the disease bladder, with the greatest accumulation within the detrusor (p<0.001). There was a significant increase in MCTC subtype in the lamina (p=0.009) in painful bladder syndrome/interstitial cystitis. CONCLUSIONS: Our results suggest that mastocytosis is present within all layers of disease bladder, especially the muscle layer. The varying increase in MC subtypes in the lamina and mucosa may explain the variability in painful bladder syndrome/interstitial cystitis symptoms. A high influx of MCTC in the mucosa of individuals who also had ulceration noted within their diagnostic notes may be of the Hunner's ulcer subclassification. These findings suggest a relationship between the pathogenesis of MC subtypes and the clinical presentation of painful bladder syndrome/interstitial cystitis. A cohort study would further elucidate the diagnostic and/or therapeutic potential of MCs in patients with painful bladder syndrome/interstitial cystitis.


Subject(s)
Cystitis, Interstitial/pathology , Mast Cells/pathology , Mastocytosis/pathology , Urinary Bladder/pathology , Biomarkers/analysis , Biopsy , Chymases/analysis , Cystitis, Interstitial/enzymology , Cystitis, Interstitial/therapy , Humans , Immunohistochemistry , Mast Cells/enzymology , Mastocytosis/enzymology , Mastocytosis/therapy , Predictive Value of Tests , Prognosis , Tryptases/analysis , Urinary Bladder/enzymology
SELECTION OF CITATIONS
SEARCH DETAIL